Switch to
View more

Solara Active Pharma Sciences Ltd

SOLARA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,245 cr, stock is ranked 902
High RiskStock is 3.40x as volatile as Nifty
349.453.50 (+1.01%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,245 cr, stock is ranked 902
High RiskStock is 3.40x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-21.42
PB RatioPB Ratio
0.78
Dividend YieldDiv. Yield
Sector PESector PE
32.93
Sector PBSector PB
4.55
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

75%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

SSL Pharma Sciences is a manufacturer of pharmaceutical preparation

Investor PresentationView older 

May 2, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20192020202120221.401.351.651.290.060.110.22-0.06
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.36%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.57%

See detailed holdings

Recent EventsAll events 

Closure of trading window 
Announced OnJun 30, 2022

Solara Active Pharma Sciences Limited has informed the Exchange about Closure of trading window | Download

Solara Active Pharma Sciences Limited has informed the Exchange about Closure of trading window | Download

Disclosure under SEBI Takeover Regulations 
Announced OnJun 28, 2022

Devicam Capital LLP has submitted to the Exchange a copy of Disclosure under Regulation 10(6) Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI ( Substantial Acquisition of Shares and takeovers) Regulations,2011 | Download

Devicam Capital LLP has submitted to the Exchange a copy of Disclosure under Regulation 10(6) Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI ( Substantial Acquisition of Shares and takeovers) Regulations,2011 | Download

Cash Dividend 
Ex. DateAug 18, 2021

Final • Div/Share: ₹ 3

See all events